8-K filed Nov 12, 2026 at 16:07 ET
NeuroPace reported Q3 2026 total revenue of $23.1M, down 1.1% YoY, and RNS System revenue growth of only 1.4%, well below prior expectations. The company slashed full-year 2026 revenue guidance to $91M-$92M from $99.5M-$101.5M, citing isolated account-level issues and field organization disruption. GAAP net loss improved to ($3.3M) from ($4.9M) a year ago, and the company achieved positive non-GAAP income from operations of $0.4M for the first time.